All Articles

By becoming the exclusive insurance partner for Huawei's luxury EVs, SunCar is embedding its AI platform deep within a new automotive power structure.

Griffon Corporation is offloading its AMES Australasia unit, but this is no fire sale. It’s a calculated JV that nets cash now and retains future upside.

HUHUTECH is pivoting from engineering services to building its own semiconductor gear, a move that could reshape its future and tap into China's tech self-sufficiency drive.

As AI demos flood Automate 2026, Datanomix stands out by proving its AI is already working, democratizing advanced analytics for manufacturers of all sizes.

Conexeu Sciences hits a key manufacturing milestone for its innovative wound-healing gel, but the path to FDA clearance and a crowded market remains a challenge.

While chips get the glory, a Wisconsin firm's strategic play in data center lighting reveals the real, power-hungry infrastructure behind the AI revolution.

A major stock conversion aims to save Alpha Modus from Nasdaq delisting. Is it a savvy financial maneuver or a last-ditch effort for its AI ambitions?

A Berkeley startup is turning old clothes into virgin-quality materials using AI-designed enzymes. This isn't just recycling; it's a new economic model.

As AI pushes data centers to their thermal limits, one company's pivot from product-maker to systems partner reveals the future of mission-critical validation.

Behind every 5G signal and autonomous car are microscopic parts. At IMS 2026, KYOCERA AVX is revealing why these unseen components are the real investment story.

Luxardo's new Decaf Espresso Liqueur isn't just a new bottle. It's a strategic move to capture the mindful drinking trend and dominate the espresso martini scene.

The promotion of Tony Pallas to CTO is no mere shuffle. It's a calculated move to arm thousands of franchisees with AI, signaling a new front in the war for hospitality tech dominance.

Hilton Hawaiian Village's legendary Rainbow Tower gets a modern, art-infused refresh, blending 65 years of history with a strategic vision for the future.

Melcor Developments is betting on itself with a massive share buyback. Is it a savvy move to exploit an undervalued stock or a bold signal of confidence?

A digital health firm is trading millions in shares for a spot on the racetrack. A deep dive into the high-octane strategy to solve healthcare access.

A new alliance between tech firm Seequent and think tank Cascade Institute aims to map Canada's vast, untapped geothermal reserves using novel AI.

Septerna's novel oral drug for hypoparathyroidism could end the tyranny of injections and supplements, but its success hinges on a bigger bet: a new system for drugging life's most difficult molecular targets.

Dr. Brian Covino's top honor signals a shift in health tech, where AI doesn't replace doctors but learns from them. Can this model fix our broken system?

A new campaign frames fusion energy as a U.S.-China security race. But beyond the hype, what is the reality of the global push for limitless power?

The AvalonBay-Equity merger just named its leaders. It's not just a new C-suite; it's a blueprint for a tech-driven, $69B titan set on dominating the rental market.